Accutane Generics Need Separate Risk Management Programs, Roche Says
Executive Summary
FDA should require that generic isotretinoin applicants implement their own pregnancy prevention programs instead of incorporating the generics into Roche's Accutane risk management program, Roche argued in a Feb. 5 citizen petition
You may also be interested in...
OxyContin ANDA Approval Delay Requested By Purdue In Petition To FDA
Purdue plans to submit a supplemental OxyContin application to include in labeling a toll-free number through which patients can get a copy of the opioid's risk management program
OxyContin ANDA Approval Delay Requested By Purdue In Petition To FDA
Purdue plans to submit a supplemental OxyContin application to include in labeling a toll-free number through which patients can get a copy of the opioid's risk management program
Mylan Generic Isotretinoin Price Will Be 90% Of Roche Accutane AWP
Mylan's branded generic isotretinoin Amnesteem will be priced at 90% of the average wholesale price of Roche's Accutane